)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Biotricity
Biotricity (BTCY) investor relations material
Biotricity Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary19 Aug, 2026
Executive summary
Revenue for the quarter ended June 30, 2026, grew 10.4% year-over-year to $4.3 million, driven by a 23.6% increase in recurring technology fee revenue, offsetting a decline in device sales.
Gross margin improved to 82.6% from 80.5% year-over-year, reflecting higher margins on technology fees and device sales.
Operating income declined 43.9% to $0.16 million due to a 26.2% increase in selling, general, and administrative expenses, mainly from higher share-based compensation.
Net loss widened to $0.96 million from $0.67 million in the prior-year quarter, with EBITDA of $90,000, down from $0.33 million, impacted by one-time share-based compensation charges.
This marks the third consecutive quarter of positive profit from operations before capital costs.
Financial highlights
Technology fee revenue reached $4.2 million, up 23.6% year-over-year, comprising 97.4% of total revenue.
Device sales declined, making up only 2.6% of total revenue.
Gross profit was $3.53 million, with a gross margin of 82.6%.
Operating expenses rose to $3.37 million, mainly due to increased share-based compensation.
Interest expense remained stable at $0.85 million.
Outlook and guidance
Management anticipates continued revenue growth and margin expansion, supported by strong customer retention and increased recurring revenue.
The company expects to improve liquidity through business development and additional equity and debt capitalization.
Ongoing investment in R&D and commercialization of new products is planned, with a focus on expanding AI-driven cardiac care solutions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Biotricity
- Revenue up 16% to $16M, net loss narrows, but liquidity concerns persist.BTCY
Q4 2026 - Profitable SaaS cardiac monitoring platform drives growth with high retention and new market expansion.BTCY16th Annual LD Micro Invitational Conference
- Third consecutive quarter of positive EBITDA, 10.2% revenue growth, and 81.5% gross margin.BTCYQ3 2026
- Strong revenue growth and margin gains, but ongoing losses and liquidity risks persist.BTCYRegistration Filing
- Annual meeting to vote on director elections, auditor ratification, and major stock issuance.BTCYProxy Filing
- Shareholders to vote on authorizing up to $20M or 20M shares in non-public offerings.BTCYProxy Filing
- Revenue up 13%, gross margin at 75.3%, and first positive EBITDA and cash flow in September 2024.BTCYQ2 2025
- Revenue up 25.2% to $12.1M, gross margin at 69.3%, but liquidity risks persist.BTCYQ4 2024
- Record revenue, margin gains, and positive cash flow, but liquidity risks remain.BTCYQ3 2025
Next Biotricity earnings date
Q2 202713 Nov, 2026
Biotricity
Next Biotricity earnings date
Q2 202713 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Biotricity Inc. is a medical technology company focused on developing and marketing remote biometric monitoring solutions for chronic health conditions. The company’s products primarily target the cardiovascular market, offering devices such as portable cardiac monitors that track and transmit real-time data for diagnostic and patient management purposes. Biotricity integrates its technology with cloud-based platforms to provide healthcare professionals with continuous monitoring and analytics. The company is headquartered in Redwood City, California, USA, and its shares are listed on the NASDAQ.